AADI BIOSCIENCE INC (AADI) Stock Price & Overview
NASDAQ:AADI • US00032Q1040
Current stock price
The current stock price of AADI is 2.05 USD. Today AADI is down by -2.38%. In the past month the price decreased by -24.07%. In the past year, price decreased by -5.96%.
AADI Key Statistics
- Market Cap
- 94.853M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.35
- Dividend Yield
- N/A
AADI Stock Performance
AADI Stock Chart
AADI Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to AADI. When comparing the yearly performance of all stocks, AADI is a bad performer in the overall market: 81.16% of all stocks are doing better.
AADI Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AADI. AADI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
AADI Earnings
On March 18, 2025 AADI reported an EPS of -0.67 and a revenue of 7.24M. The company missed EPS expectations (-198.57% surprise) and missed revenue expectations (-4.74% surprise).
AADI Forecast & Estimates
8 analysts have analysed AADI and the average price target is 3.06 USD. This implies a price increase of 49.27% is expected in the next year compared to the current price of 2.05.
For the next year, analysts expect an EPS growth of 71.14% and a revenue growth -46.53% for AADI
AADI Groups
Sector & Classification
AADI Financial Highlights
Over the last trailing twelve months AADI reported a non-GAAP Earnings per Share(EPS) of -2.35. The EPS increased by 3.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -71.98% | ||
| ROE | -89.57% | ||
| Debt/Equity | 0 |
AADI Ownership
AADI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 13.82 | 364.65B | ||
| AMGN | AMGEN INC | 15.24 | 188.631B | ||
| GILD | GILEAD SCIENCES INC | 15.52 | 175.177B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.42 | 116.358B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.68 | 77.963B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 41.84 | 41.258B | ||
| INSM | INSMED INC | N/A | 31.039B | ||
| NTRA | NATERA INC | N/A | 28.733B | ||
| BIIB | BIOGEN INC | 11.29 | 26.917B | ||
| UTHR | UNITED THERAPEUTICS CORP | 17.55 | 23.098B | ||
| MRNA | MODERNA INC | N/A | 20.683B | ||
| EXAS | EXACT SCIENCES CORP | 345.14 | 19.837B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.676B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AADI
Company Profile
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Pacific Palisades, California and currently employs 53 full-time employees. The company went IPO on 2018-06-26. The firm is focused on applying technology to deliver improved precision oncology therapies for people living with difficult-to-treat cancers.
Company Info
IPO: 2018-06-26
AADI BIOSCIENCE INC
17383 Sunset Avenue, Suite A250
Pacific Palisades CALIFORNIA US
CEO: Joseph Gardner
Employees: 53
Phone: 14244738055
AADI BIOSCIENCE INC / AADI FAQ
What does AADI BIOSCIENCE INC do?
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Pacific Palisades, California and currently employs 53 full-time employees. The company went IPO on 2018-06-26. The firm is focused on applying technology to deliver improved precision oncology therapies for people living with difficult-to-treat cancers.
What is the current price of AADI stock?
The current stock price of AADI is 2.05 USD. The price decreased by -2.38% in the last trading session.
Does AADI stock pay dividends?
AADI does not pay a dividend.
How is the ChartMill rating for AADI BIOSCIENCE INC?
AADI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How many employees does AADI BIOSCIENCE INC have?
AADI BIOSCIENCE INC (AADI) currently has 53 employees.
Can you provide the market cap for AADI BIOSCIENCE INC?
AADI BIOSCIENCE INC (AADI) has a market capitalization of 94.85M USD. This makes AADI a Micro Cap stock.
Can you provide the upcoming earnings date for AADI BIOSCIENCE INC?
AADI BIOSCIENCE INC (AADI) will report earnings on 2025-05-06, before the market open.